Court approves pSvida re-incorporation
Wednesday, 11 June, 2008
WA biotech pSvida (ASX: PSD) has received court approval to re-incorporate in the US, paving the way for the company to be re-listed on the NASDAQ stock exchange.
The company announced yesterday that the Federal Court of Australia had approved its reincorporation proposals.
The reincorporation will take effect today, and pSvida shares will start trading on NASDAQ starting today or Thursday.
As part of the process, pSvida will cease trading shares on the ASX, and won't resume full ASX trading until June 26.
pSvida will also begin trading on the Frankfurt Stock Exchange on Thursday.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
